ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Vaccinex Inc

Vaccinex Inc (VCNX)

4.45
0.32
( 7.75% )
Updated: 13:10:27

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
4.45
Bid
4.45
Ask
4.60
Volume
84,196
3.9496 Day's Range 4.54
1.39 52 Week Range 13.02
Market Cap
Previous Close
4.13
Open
3.96
Last Trade
160
@
4.45
Last Trade Time
13:10:27
Financial Volume
$ 345,702
VWAP
4.1059
Average Volume (3m)
106,768
Shares Outstanding
2,599,728
Dividend Yield
-
PE Ratio
-0.56
Earnings Per Share (EPS)
-7.79
Revenue
570k
Net Profit
-20.25M

About Vaccinex Inc

Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline... Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline includes pepinemab (VX15), which targets Huntington's Disease (HD) and non-small cell lung cancer (NSCLC) and also neurodegenerative disorders; VX5 Autoimmune for the treatment of MS and potentially for other autoimmune disorder; and others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Vaccinex Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VCNX. The last closing price for Vaccinex was $4.13. Over the last year, Vaccinex shares have traded in a share price range of $ 1.39 to $ 13.02.

Vaccinex currently has 2,599,728 shares outstanding. The market capitalization of Vaccinex is $10.74 million. Vaccinex has a price to earnings ratio (PE ratio) of -0.56.

VCNX Latest News

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a...

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

ROCHESTER, N.Y., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and...

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

ROCHESTER, N.Y., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and...

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain

ROCHESTER, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Vaccinex (Nasdaq: VCNX) today provided an update on new clinical findings from its SIGNAL-AD Phase 1b/2 trial of pepinemab antibody in...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.821.91780821923.654.62753.14011032903.96670028CS
41.2639.49843260193.194.62752.8746922563.48027008CS
12-0.94-17.4397031545.3961.391067683.09962981CS
26-2.32-34.26883308716.778.91.39904034.38898425CS
52-4.65-51.09890109899.113.021.39739766.27125411CS
156-310.55-98.5873015873315478.81.39288522149.76931453CS
260-1037.15-99.57277265751041.62568.31.39596053682.90989171CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTNTCheetah Net Supply Chain Service Inc
$ 5.75
(207.49%)
107.18M
ZJKZJK Industrial Company Ltd
$ 15.22
(140.06%)
19.39M
JYDJayud Global Logistics Ltd
$ 1.185
(76.84%)
5.87M
GWAVGreenwave Technology Solutions Inc
$ 0.5812
(59.23%)
350.59M
JANXJanux Therapeutics Inc
$ 62.055
(54.44%)
5.46M
REVBRevelation Biosciences Inc
$ 0.56
(-41.05%)
3.52M
STSSSharps Technology Inc
$ 2.2386
(-33.25%)
299.79k
GELSGelteq Ltd
$ 2.6136
(-31.59%)
235.13k
OMEXOdyssey Marine Exploration Inc
$ 0.51
(-31.56%)
3.36M
SGBXSafe and Green Holdings Corporation
$ 0.4944
(-27.72%)
3.13M
GWAVGreenwave Technology Solutions Inc
$ 0.5812
(59.23%)
350.59M
SMCISuper Micro Computer Inc
$ 41.51
(-1.17%)
161.22M
CTNTCheetah Net Supply Chain Service Inc
$ 5.75
(207.49%)
107.18M
CHRSCoherus BioSciences Inc
$ 2.0177
(47.28%)
101.01M
CTORCitius Oncology Inc
$ 1.4408
(41.25%)
97.02M

VCNX Discussion

View Posts
dinogreeves dinogreeves 9 minutes ago
Trading beautifully. Double digits in sight without a doubt.
👍️0
dinogreeves dinogreeves 20 hours ago
Probably because they are not compliant yet, they have a meeting with Nasdaq on the 5th. E Trade is the best platform by far. Once they are in compliant this will run, plus their patent just got approved but they haven't released the news yet.
👍️0
tw0122 tw0122 21 hours ago
Vaccinex (VCNX) 11/7 $4.13 + 9% announced the signing of several proprietary project agreements with Amgen (AMGN), Merck (MRK), Chugai, Absci (ABSI), Gigagen (Grifols), Merus (MRUS), Soleil, ThirdArc and Incyte (INCY), employing Vaccinex's ActivMAb technology to generate antibodies to complex antigen targets. In addition, Vaccinex has signed agreements to provide Charles River Labs, OmniAb, Adimab and other undisclosed strategic partners with materials to facilitate their antibody discovery programs using transgenic animal species for immunization or very large synthetic antibody libraries. The financial terms of the agreements are undisclosed.
👍️0
buzzonthestreet buzzonthestreet 1 day ago
Fidelity won’t let me buy/! Why? Anybody know?
👍️0
dinogreeves dinogreeves 1 day ago
VCNX will hit 30-40 dollars in a blink and triple dollars in within 18 months. No ifs or buts. This is buy and hold for dear life.
👍️0
dinogreeves dinogreeves 1 day ago
That was given, it only made common sense, when they haven't been diluting since the dawn of times, they haven't cooked the numbers.
👍️0
eur06 eur06 1 day ago
The other one is approaching 40!
👍️0
eur06 eur06 1 day ago
Wow 2M is a lot!!
VCNX
👍️0
dinogreeves dinogreeves 1 day ago
This one will give big in due time. Another insider buy over 2 million dollars off the market on 11/14. They know its coming, barely seen a micro cap biotech with insiders too confident.
👍️0
eur06 eur06 1 day ago
Good for you dino.
We’re close I guess!!
👍️0
dinogreeves dinogreeves 1 day ago
Bought another 500 shares just now. Once this goes it's gone.
👍️0
eur06 eur06 3 days ago
A tiny piece , but just to monitor how it’ll end up years from now.
I’m curious about these things and btw company I think is good.
About the stock dunno.
👍️0
BurgerKing82 BurgerKing82 3 days ago
Hi eur06, do ya still own sevc*q?... Just curious
👍️0
dinogreeves dinogreeves 5 days ago
This price stays this range, since I plan on buying another 600-700 shares on Friday, will bring my tally up to 6200 shares, just need another 3800 shares, which I plan on buying right before the 5th of December and that bring my tally up to 10,000 shares and wait for news and no, I will be not be selling for 100%.....200% gains either, this is easily worth minimum 30-40 dollars, which is ten times from here, got all the time in the World.
👍️0
dinogreeves dinogreeves 6 days ago
Interesting high of the day today $3.94 with nothing burger volume, imagine with great news volume goes through the roof and float almost locked up. The last days this will stay under $4.00 is first week December, after that once they go compliant easy $5-6 dollars with news, this will be run to remember.
👍️0
Jagman5 Jagman5 7 days ago
Yes, read the filings.

$VCNX
👍️0
bonzai_bob bonzai_bob 1 week ago
Been watching this; did the outstanding just go from 1.7M to 2.6M?
👍️0
dinogreeves dinogreeves 1 week ago
Tariffs will hurt US companies importing their goods from China, Mexico and Canada, Harbor Freight was planning on more locations Nationwide, now with these Tariffs, they put a freeze on store build out locations. Companies that make their products here in US are going to be immune. Market already sees this, whether that will change in the morning, is yet to be determined.
👍️ 1
dinogreeves dinogreeves 1 week ago
Tariffs won't hurt this company, US made products and 60% of their products is sold in the US, it will make this company even stronger. The massive run starts first to second week of December. End of the year price target 60-70 dollars.
👍️ 1 💯 1
dinogreeves dinogreeves 1 week ago
VCNX is getting marinated and prepped for a major run. How fast and far up, all depends on what the insiders motives are. The science is one of the best breeds out there. This could fly to 20 dollars and still be cheap. Hands down the next DRU*G in the making and even higher in the triple dollars range.
👍️0
dinogreeves dinogreeves 1 week ago
Euro, this one is a hold for dear life.
👍️0
eur06 eur06 1 week ago
Wow past Nasdaq meeting Dec 5th for sure we’ll know about these agreements.
Also starting tomorrow something may come our way before that date.
VCNX
👍️0
dinogreeves dinogreeves 1 week ago
👍️0
dinogreeves dinogreeves 1 week ago
👍️0
dinogreeves dinogreeves 1 week ago
"I just don't get how this isn't $100/share right now, makes no sense. This is vs a 60% success rate without Pepinemab."

Amazing science.
👍️0
dinogreeves dinogreeves 1 week ago
Here is the last post by Kobes. This is personally from me, not Kobes, Kobes quote is below. I too believe there is going to be partnership, if there is going to be buyout, it will be before the compliant, which falls first to second week of December, if we get past that, then it is partnership. Regardless, this will get to triple dollars within the timeline I expect, this is a hold for dear life.

"I don't have a Crystal Ball I wish I did, but here's how I'm seeing it;

Partnership Logic -
Every single form I've ran through from as far back as 2018 they stated very clearly that their intentions are to capitalize on existing collaborations to expand into partnerships to advance towards commercialization. Specifically mentioning the Cancer trials with Merck.

They've stated clearly they're seeking a partnership. Now if they're seeking a partnership on Neurology side it could be with Biogen, Roche, Merck, I originally thought Eli Lilly but the more research I did the more I found Roche has been interested as well.

A partnership is possible in the form of Royalties, Commercialization agreement with sales percentages, etc. This would give them an influx of money to concentrate on other pipeline avenues such as melanoma, breast cancer, Rett Syndrome, etc.

If this was the appeal plan I wouldn't expect an instant jump in value unless someone buys those 1.6million shares or the Partnership is incredibly good.

Buyout Logic - They're in a deep deficit with lack of cash to push more trials without an influx of money not even including compliance. This does seem the most logical at first thought and Hopium

IMO

After researching over past forms, documents, down to current statements, future growth in pipeline, down to purchases, Alzheimer's Association Warrants, and company warrants.....

Partnership, as much as I want a buyout, Partnership seems like the path they're going based on the information I have on hand from last night.
-With the Alzheimer's Association not executing the warrants
-The company having the ability to execute the warrants on their behalf and haven't
-The amount of warrants lately with the ability to purchase more
-Past & Current statements on Partnerships through current collaborations
-Dr Siemers wasn't working on Eli Lilly's behalf but on behalf of Alzheimer's Association, interesting I know, in fact he is Chief Medical Officer of another pharma company right now.
-Past filed forms make it pretty evident they made some form of mutual agreement with Merck on the Cancer trials based on endpoint being met.

All this together makes me think they already have a partner for Neurology or Oncology side or both and are negotiating the terms of said strategic partnership.

The amount of warrants, setting aside the 1.6million shares, Alzheimer's Association not executing their warrants.....just doesn't say buyout it says Partnership and that would make sense if they're all confident on the results and the ability to execute a partnership this is what you would do knowing the value is there longer term.
After looking over the pipeline ability of Pepinemab the value IMO would be over 10billion starting price. At that point it makes more sense to create the next Merck, Eli Lilly, Roche, the next Large pharmaceutical giant."
👍️0
eur06 eur06 1 week ago
I believe you are right, I’m ready and very very excited about this situation!!
VCNX
👍️0
dinogreeves dinogreeves 1 week ago
I am extremely convinced that VCNX will hit triple dollars in 18 months or less. Just give me buyout at 500 million dollars $195 dollars or a billion dollars for twice more. Outstanding science, this is one of the best of best breed in this sector.
👍️0
eur06 eur06 2 weeks ago
“December to remember “ nice ring.
👍️0
dinogreeves dinogreeves 2 weeks ago
December to remember. One of the best low market cap biotech company out there. This has 200 million market cap written all over it. I know it, when I see it.
👍️0
dinogreeves dinogreeves 2 weeks ago
Not much time left till compliant news from Nasdaq, first week or second week of December to remember.
👍️0
dinogreeves dinogreeves 2 weeks ago
Oh boy!!! Going for another 500 shares by end of the day.
👍️0
dinogreeves dinogreeves 2 weeks ago
👍️0
dinogreeves dinogreeves 2 weeks ago
$4-5 range then Nasdaq compliance, then big news. They will hold it down until compliance.
👍️0
eur06 eur06 2 weeks ago
Thanks dino.
I managed to find, read and connect the dots over there as you said.
So all this hush-hush from the company seems to have a meaning ….likely interested parties met and are about to act.
Combine that with the upcoming Nasdaq meeting due in two weeks and we can explain the ultra-aggressive tight trading.
I wonder if we get a ‘revelation’ before that date.
VCNX
👍️0
dinogreeves dinogreeves 2 weeks ago
Euro, there is new DD on this one, Kobe is very good, but there is one other poster on Stocktwits that found something that blew Kobe away, needless to say, all the DD on that board is very intriguing, but this stock is incredibly intriguing, I think it is going to blow the lid off, the float is getting tighter and tighter and only the insiders and Steve Cohen know where it going once that news breaks, I hate to tell you this, I think this will easily hit 100 million market, which is 10 times from here. One great news, we are off to the races. The insiders are very old, so might even sell the company, someone is definitely manipulating the stock with the pattern it has had lately. Just stick around and buy any dips you can, I have already accumulated 5000 shares and waiting on a big payday, most of trading funds are tied to SMCI, had to average down on that one, otherwise I would allocated them here after what I read tonight.
👍️0
eur06 eur06 2 weeks ago
I’m doing just that, they let you buy at 3.35 but after that is immediately taken back down to $3 as if their lives depended on it.
In any case it’s ok ..it’ll turn around.
NCVX
👍️0
dinogreeves dinogreeves 2 weeks ago
This will move to triple dollars, don't know when but it will. Just add 100 shares a day if you can. Wasn't home most of the day, I am committed to this and a few others, waiting for SMCI to hit my target price too, not going anywhere with that one for sure.
👍️0
eur06 eur06 2 weeks ago
Yes, they don't let it move above 3.3-3-4
👍️0
dinogreeves dinogreeves 2 weeks ago
Looks like a holding pattern.
👍️0
dinogreeves dinogreeves 2 weeks ago
Stick around, we should expect some good news relatively soon, 1-3 weeks. We just add at this range.
👍️0
eur06 eur06 2 weeks ago
Still here…was trying to add at 3.26 but nada…they wanted 3.34.
Got enough though thank you dino!
VCNX
👍️0
dinogreeves dinogreeves 2 weeks ago
For the record I am still here, if anyone one of my followers decide to leave, leave at your own peril. This is not for everyone but when that news breaks this will get to 100 million market cap in a blink and that is minimum 10 times from here.
👍️0
eur06 eur06 2 weeks ago
I am ready dino!!!
Let’s go.
VCNX
👍️0
dinogreeves dinogreeves 2 weeks ago
One awesome news and the lid will blow off this powder keg.
👍️0
eur06 eur06 2 weeks ago
I'm in and intentioned to stay put and add as I can!!
I read some of the publications.
Thank you as usual for sharing and for having found it.
VCNX
👍️0
dinogreeves dinogreeves 3 weeks ago
Next news this is going to be trending a lot higher. I kid you not, this is the next DRU*G in the making. Buy, buy anything below 3.75 and even 4 dollars, for crying out loud, the insider have bought 5.65, they swallowed up all the last offering themselves. One of the best science out there, this is going to triple dollars in less than 18 months.
👍️0
dinogreeves dinogreeves 3 weeks ago
This ticker has everything to be the next huge biotech in due time. You sell here, you will be crying, I don't care about what's in the books, it's the science, the science is mind blowing.
👍️0
eur06 eur06 3 weeks ago
Next PR we might know how much the numerous Pharmaceutical companies pay to use their ActivMAb platform!!!
No wonder insiders are buying.
👍️0
eur06 eur06 3 weeks ago
I didn’t see them yet….!
I’m ready and excited!!
VCNX
👍️0